Antibodies
1 October 2007
Preclinical Study Published in Nature Medicine Shows Anti-LINGO-1 AntibodyPromotes Remyelination28 September 2007
Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study28 September 2007
Crucell discovers human monoclonal antibodies for the prevention and treatment of the avian flu virus27 September 2007
Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis26 September 2007
Abbott and Eisai submit application for adalimumab, the only fully human monoclonal anti-TNFalpha antibody, to treat psoriasis26 September 2007
New Biomarker Data Links KRAS Gene to Vectibix(TM) Clinical Response22 September 2007
Vectibix(TM) (panitumumab) Receives Positive Opinion for Marketing Authorization in the European Union21 September 2007
FDA Approves Expanded Labeling for Campath® to Include First-line Treatment for Leading Form of Adult Leukemia19 September 2007
LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies19 September 2007
Antitope Announces Research Agreement with Fraunhofer Institute for Cell Therapy and Immunology14 September 2007
Genmab Discloses Target and Development Plans for HuMax-Inflam14 September 2007
Genmab Provides Insights into IgG4 Antibodies11 September 2007
Merck: Erbitux Phase III Study – FLEX Increases Overall Survival in First-line Treatment of Non-Small Cell Lung Cancer11 September 2007
Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis8 September 2007
Ablynx and Boehringer Ingelheim announce major global strategic alliance to discover, develop and commercialise novel nanobody(R) therapeutics8 September 2007
ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-4028 September 2007
Genmab announces encouraging preclinical data for Ofatumumab6 September 2007
Medarex Announces Extension of Broad Antibody Development Relationship with Centocor6 September 2007
Dyax Corp. and Bayer Schering Pharma AG Enter Into a Collaboration Agreement for Discovery of Therapeutic Antibodies5 September 2007
YM BioSciences Announces positive preliminary results from Phase I/II lung cancer trial of nimotuzumab combined with radiationNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports